Has Daniel K. Spiegelman been buying or selling shares of Myriad Genetics?
Daniel K. Spiegelman has not been actively trading shares of Myriad Genetics within the last three months. Most recently, Daniel K. Spiegelman sold 6,424 shares of the business's stock in a transaction on Monday, June 6th. The shares were sold at an average price of $19.25, for a transaction totalling $123,662.00. Following the completion of the sale, the director now directly owns 33,980 shares of the company's stock, valued at $654,115. Learn More on Daniel K. Spiegelman's trading history.